Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	n.A.	-0.87	n.A.
Graham Fair Price	100.00	4.44	0.00
PEG	0.00	0.00	0.00
Price/Book	100.00	0.29	0.00
Price/Cash Flow	100.00	2.12	0.00
Prices/Earnings	-100.00	-4.14	0.00
Price/Sales	100.00	0.38	0.00
Price/FCF	100.00	2.12	0.00
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-17.64	-0.82	1.00
Operating Margin	-49.33	0.07	0.13
ROA	-100.00	< 0.005	0.00
ROE	0.00	-0.02	-100.00
ROIC	0.00	0.01	100.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.08	0.00	-100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	-0.60	-100.00
EPS QOQ	0.00	0.00	0.00
FCF QOQ	0.00	0.11	100.00
Revenue QOQ	0.00	-0.21	-100.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	27.05	100.00
Days Sales Outstanding (DSO)	n.A.	43.47	n.A.
Inventory Turnover	0.00	3.33	100.00
Debt/Capitalization	0.00	0.19	100.00
Quick Ratio	0.00	0.69	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.00	7.11	100.00
Cash	0.00	3.92	100.00
Capex	0.00	-0.35	-100.00
Free Cash Flow	0.00	0.96	100.00
Revenue	0.00	5.43	100.00
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.00	1.06	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	n.A.	-11.52	n.A.
Naive Interpretation	Member

06 - Financial Health · Bad

Rating